期刊文献+

负载不同形式肝癌抗原的树突状细胞抑瘤功能的比较 被引量:5

Comparison of antitumor effects of dendritic cells modified with different forms of hepatocellular cancer antigens
下载PDF
导出
摘要  目的:探讨不同形式的肝癌抗原修饰的树突状细胞(DC)的抑瘤功能。方法:分别用肝癌H22冻融抗原、H22小分子抗原肽和Hsp70-H22抗原肽复合物修饰DC;用MTT比色法分析DC激活的CTL对H22细胞的杀伤能力,并用RT PCR法测定脾脏T细胞中IFN-γmRNA的表达水平;用不同修饰的DC免疫小鼠,观察其对H22肝癌的生长抑制作用。结果:单独的H22肝癌抗原肽修饰的DC不能激活CTL。Hsp70-H22肽复合物修饰的DC激活CTL的能力强于H22肝癌冻融抗原修饰的DC,对H22细胞的杀伤率分别为 47. 3%和 18. 3%。各组T细胞中IFN-γ表达水平的变化与杀伤率的变化相一致。用H22肝癌冻融抗原和Hsp70 -H22肽复合物修饰的DC免疫小鼠后,均可抑制H22细胞生长,但后者的抑制作用更强,成瘤率仅 40%。其他各组的成瘤率均为100%。结论:Hsp70-H22肽复合物是一种DC的强致敏物,可通过激活CTL、诱导CD4+T细胞分化成Th1型细胞而参与肝癌的免疫排斥。
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2005年第1期100-102,117,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家重点基础研究发展规划 ( 973 )资助 (No.2002CB513100)
  • 相关文献

参考文献13

  • 1Stift A, Friedl J, Dubsky P, et al. Dendritic cell-based vaccination in solid cancer[J]. J Clin Oncol, 2003, 21(1): 135- 142.
  • 2Marten A, Flieger D, Renoth S, et al. Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial[J]. Cancer Immunol Immunother, 2002, 51(11-12): 637-644.
  • 3Lambert LA, Gibson GR, Maloney M, et al. Intranodal immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor immunity[J]. Cancer Res, 2001, 61(2): 641-646.
  • 4Blachere NE, Li ZH, Rajiv Y, et al. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity[J]. J Exp Med, 1997, 186 (8): 1315-1322.
  • 5Vendetti S, Chai JG, Dyson J, et al. Anergic T cells inhibit the antigen-presenting function of dendritic cells[J]. J Immunol, 2000, 165: 1175-1181.
  • 6Curiel TJ, Wei S, Dong H, et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity[J]. Nat Med, 2003, 9(5): 562-567.
  • 7Kakumu S, Ito S, Ishikawa T, et al. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection[J]. J Gastroenterol Hepatol, 2000, 15(4): 431-436.
  • 8Kohrgruber N, Halanek N, Winter D, et al. Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines[J]. J Immunol, 1999, 163: 3250-3259.
  • 9Ridgway D. The first 1000 dendritic cell vaccines[J]. Cancer Invest, 2003, 21(6): 873-886.
  • 10DeMatos P, Abdel-Wahab Z, Vervaert C, et al. Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice[J]. J Surg Oncol, 1998, 68(2): 79-91.

同被引文献47

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部